Novo Nordisk Cuts Ozempic Price to $499 for US Cash Patients
TL;DR Summary
Novo Nordisk now offers Ozempic for $499 a month for cash-paying patients through its direct-to-consumer pharmacy and partnerships, aiming to make the costly diabetes drug more accessible amid ongoing debates over drug prices in the US.
- US patients can now get Ozempic for half price if they can pay cash CNN
- GoodRx stock soars after striking deal to sell Novo Nordisk's GLP-1s for $499/month Yahoo Finance
- Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients CNBC
- Novo Nordisk offers Ozempic at $499 per month to eligible US cash-paying customers Reuters
- Novo Nordisk halves US price of Ozempic Financial Times
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
2 min
vs 2 min read
Condensed
91%
397 → 36 words
Want the full story? Read the original article
Read on CNN